Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID
Active, not recruiting · NCT06161688 · Registry updated 2026-04-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID | COVID-19, Chronic Disease, Coronaviridae Infections, Disease Attributes, Infections, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, long COVID-19, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder, viral infectious disease, viral pneumonia | Active, not recruiting | Phase 2 | 2026-04-02 | NCT06161688 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shionogi Inc. | 2 |
| Timothy Henrich | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UCSF/Zuckerberg San Francisco General Hospital | San Francisco | United States | 2 |